Search research articles
Contact Us
Filters
Showing results (371-380 of 403) with videos related to
Page
of 41
Sort By:
Protein & Cell
|
September 23, 2021
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
Zezhong Liu, Wei Xu, Zhenguo Chen, et al.
BMC Biology
|
October 2, 2023
Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history
Anqi Xia, Xiaojie Wang, Jiaying He, et al.
Immunity
|
March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Nature Communications
|
November 26, 2025
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution
Minxiang Xie, Yinong Qiu, Xiaoyu Zhao, et al.
European Journal of Immunology
|
October 28, 2022
Guidelines for mouse and human DC generation
Manfred B Lutz, Shafaqat Ali, Cindy Audiger, et al.
Plos One
|
November 11, 2024
A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions
Sedem Dankwa, Christina Kosman, Maria Dennis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 2, 2025
Hydrogel formulations for sustained-release of broadly neutralizing antibodies
Carolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Vaccine
|
June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial
Joel V Chua, Charles Davis, Jennifer S Husson, et al.
Research Square
|
November 28, 2024
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Nature Communications
|
February 21, 2025
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 403) with videos related to
Sort By:
Page
of 41
Protein & Cell
|
September 23, 2021
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
Zezhong Liu, Wei Xu, Zhenguo Chen, et al.
BMC Biology
|
October 2, 2023
Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history
Anqi Xia, Xiaojie Wang, Jiaying He, et al.
Immunity
|
March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Nature Communications
|
November 26, 2025
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution
Minxiang Xie, Yinong Qiu, Xiaoyu Zhao, et al.
European Journal of Immunology
|
October 28, 2022
Guidelines for mouse and human DC generation
Manfred B Lutz, Shafaqat Ali, Cindy Audiger, et al.
Plos One
|
November 11, 2024
A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions
Sedem Dankwa, Christina Kosman, Maria Dennis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 2, 2025
Hydrogel formulations for sustained-release of broadly neutralizing antibodies
Carolyn K Jons, Catherine M Kasse, Bryan T Mayer, et al.
Vaccine
|
June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial
Joel V Chua, Charles Davis, Jennifer S Husson, et al.
Research Square
|
November 28, 2024
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Nature Communications
|
February 21, 2025
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Page
of 41